Clinical Trial Update: Regulatory Post Marketing Surveillance Study on YAZ

View source ↗

Summary

Completed regulatory post-marketing surveillance study on Yaz (drospirenone/ethinyl estradiol) sponsored by Bayer, evaluating contraception, premenstrual syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Premenstrual Syndrome

Drugs mentioned

• YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

Sponsor: Bayer | Conditions: Contraception, Premenstrual Syndrome | Status: COMPLETED